Sof foyda bo'yicha sotuv rentabelligi: Citius Oncology (CTOR)

Citius Oncology, Inc. (CTOR) tovar belgisi

Citius Oncology, Inc. (CTOR) dori vositalarini ishlab chiqishda bioetika va ekologik barqarorlik tamoyillariga rioya qilgan holda o'z biznesini kengaytirmoqda. GURU.Markets portalidagi savdo marjasi chuqurligi foyda dinamikasini aks ettiradi, bunda -648.30 qiymati ushbu ko'rsatkichni ifodalaydi. Terapiyaga bo'lgan talab iqtisodiy sharoitlardan mustaqil qolgan bo'lsa-da, joriy likvidlik tanqisligi yangi dori vositalarini bozorga chiqarish bilan bog'liq xarajatlar tufayli yuzaga kelmoqda.

citiusonc.com (CTOR) Kompaniya sotuv marjasi: 14.08.2024 - 20.11.2026 davri uchun

Citius Oncology, Inc. kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Citius Oncology Inc. - CTOR
Citius Oncology, Inc ishlab chiqargan mahsulot

Citius Oncology, Inc. (CTOR) kompaniyasining kichik molekulali bioinzheneriyadagi yuqori ilmiy salohiyati ulkan R&D xarajatlarini talab qiladi, bu esa daromadning har bir birligining yakuniy rentabelligiga bevosita ta'sir ko'rsatadi. Biznesning sof marja samaradorligini tahlil qilish barcha xarajatlardan keyingi foyda ulushini baholash imkonini beradi, bu esa operatsion muvaffaqiyatlarni bozor qiymatiga aylantiradi va choraklik hisobotlar bilan bog'liq vaqt kechikishlarini bartaraf etadi.

Asosiy raqobatchilar

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)